COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
View ORCID ProfileDavid Emes, View ORCID ProfileAnke Hüls, Nicole Baumer, View ORCID ProfileMara Dierssen, Shiela Puri, Lauren Russel, Stephanie L. Sherman, View ORCID ProfileAndre Strydom, View ORCID ProfileStefania Bargagna, Ana Cláudia Brandão, View ORCID ProfileAlberto C.S. Costa, Brian Allen Chicoine, View ORCID ProfileSujay Ghosh, View ORCID ProfileAnne-Sophie Rebillat, View ORCID ProfileGiuseppina Sgandurra, View ORCID ProfileDiletta Valentini, View ORCID ProfileTilman R. Rohrer, View ORCID ProfileJohannes Levin, View ORCID ProfileMonica Lakhanpaul, The Trisomy 21 Research Society COVID-19 Initiative
doi: https://doi.org/10.1101/2021.06.25.21259525
David Emes
1Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK
Anke Hüls
2Department of Epidemiology and Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Nicole Baumer
3Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA
Mara Dierssen
4Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Doctor Aiguader 88,Barcelona, Spain. Universitat Pompeu Fabra (UPF), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain
Shiela Puri
5Down Syndrome Medical Interest Group UK. Leeds Community Healthcare NHS Trust
Lauren Russel
6Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
Stephanie L. Sherman
7Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia, USA
Andre Strydom
8Institute of Psychiatry, Psychology, and Neuroscience, Department of Forensic and Neurodevelopmental Sciences, King’s College London, London, United Kingdom; The London Down Syndrome (LonDownS) Consortium, London, United Kingdom; South London and the Maudsley NHS Foundation Trust
Stefania Bargagna
9Fondazione Stella Maris IRCCS, Pisa, Italy
Ana Cláudia Brandão
10Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil
Alberto C.S. Costa
11Departments of Pediatrics and of Psychiatry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
Brian Allen Chicoine
12Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL, USA
Sujay Ghosh
13Cytogenetics and Genomics Research Unit. Department of Zoology, University of Calcutta.Kolkata. West Bengal, India
Anne-Sophie Rebillat
14Institut Jérôme Lejeune, Paris, France
Giuseppina Sgandurra
15Department of Developmental Neuroscience, IRCCS Fondazione Stella Maris, Pisa, Italy; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Diletta Valentini
16Pediatric Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
Tilman R. Rohrer
17Division of Pediatric Endocrinology, Saarland University Medical Center, Homburg/Saar, Germany
Johannes Levin
18Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany. German Center for Neurodegenerative Diseases, site Munich. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
Monica Lakhanpaul
19UCL- Great Ormond Street Institute of Child Health, London, United Kingdom; Whittington NHS Trust, London, United Kingdom; Down Syndrome Medical Interest Group, London, United Kingdom

Data Availability
Data used are drawn from international surveys, which are cited and made accessible to readers
Posted July 02, 2021.
COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
David Emes, Anke Hüls, Nicole Baumer, Mara Dierssen, Shiela Puri, Lauren Russel, Stephanie L. Sherman, Andre Strydom, Stefania Bargagna, Ana Cláudia Brandão, Alberto C.S. Costa, Brian Allen Chicoine, Sujay Ghosh, Anne-Sophie Rebillat, Giuseppina Sgandurra, Diletta Valentini, Tilman R. Rohrer, Johannes Levin, Monica Lakhanpaul, The Trisomy 21 Research Society COVID-19 Initiative
medRxiv 2021.06.25.21259525; doi: https://doi.org/10.1101/2021.06.25.21259525
COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
David Emes, Anke Hüls, Nicole Baumer, Mara Dierssen, Shiela Puri, Lauren Russel, Stephanie L. Sherman, Andre Strydom, Stefania Bargagna, Ana Cláudia Brandão, Alberto C.S. Costa, Brian Allen Chicoine, Sujay Ghosh, Anne-Sophie Rebillat, Giuseppina Sgandurra, Diletta Valentini, Tilman R. Rohrer, Johannes Levin, Monica Lakhanpaul, The Trisomy 21 Research Society COVID-19 Initiative
medRxiv 2021.06.25.21259525; doi: https://doi.org/10.1101/2021.06.25.21259525
Subject Area
Subject Areas
- Addiction Medicine (227)
- Allergy and Immunology (502)
- Anesthesia (110)
- Cardiovascular Medicine (1234)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10015)
- Gastroenterology (499)
- Genetic and Genomic Medicine (2449)
- Geriatric Medicine (236)
- Health Economics (479)
- Health Informatics (1639)
- Health Policy (752)
- Hematology (248)
- HIV/AIDS (532)
- Medical Education (252)
- Medical Ethics (74)
- Nephrology (268)
- Neurology (2278)
- Nursing (139)
- Nutrition (350)
- Oncology (1245)
- Ophthalmology (375)
- Orthopedics (133)
- Otolaryngology (226)
- Pain Medicine (155)
- Palliative Medicine (50)
- Pathology (324)
- Pediatrics (729)
- Primary Care Research (282)
- Public and Global Health (4829)
- Radiology and Imaging (834)
- Respiratory Medicine (651)
- Rheumatology (283)
- Sports Medicine (226)
- Surgery (267)
- Toxicology (44)
- Transplantation (125)
- Urology (99)